WHO launches global megatrial of the four most promising coronavirus treatments/ Science mag

Here's the story.

Oddly, the WHO was initially going to omit studying the cheapest drugs, chloroquine and hydroxychloroquine, despite support for them by Chinese doctors here and here and French doctors.  But now both have been added to WHO's mega COVID-19 trial.